Impact study of telephone follow-up in onco-haematological treatment<\/h1>\n\u2014 C\u00f4te d’Ivoire \u2014<\/span><\/em><\/h3>\n<\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div>![\"Etude](\"https:\/\/www.fondationpierrefabre.org\/wp-content\/uploads\/sites\/2\/2018\/12\/amafrica_principal-def-1.jpg\" "\\"amafrica_principal-def")
<\/span><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div>BACKGROUND<\/strong><\/span><\/p>\n<\/div>\n<\/div><\/div><\/div>In 2006, at the University Hospital (CHU) of Toulouse, the AMA project was born (Assistance M\u00e9dicale Ambulatoire, or outpatient medical support). Objectives: to assess the effectiveness of telephone follow-up in improving onco-haematology patients\u2019 compliance with dose intensity<\/strong>. Seven years later, the project has show very positive results, with an average dose reduction of 8%, compared to 20% without follow-up \u2013 all due to a simple and inexpensive procedure.<\/p>\nIn 2015, Prof. Laurent, encouraged by these achievements, suggested duplicating the study in Ivory Coast, where nearly 20,000 new cancer cases are reported annually, with a 60% treatment refusal and dropout rate, and a 20% survival rate at five years. The project, financed by Fondation Pierre Fabre, took the new name AMAFRICA. A simple, monocentric, randomised study will be conducted in collaboration with the onco-haematology department at the Abidjan University Hospital, headed by Professor Koffi. The central hypothesis is that consistent telephone contact with the patient by a coordinating nurse could reduce the dropout rate (primary objective), but also help identify and prioritise the causes of treatment dropout (secondary objective).<\/p>\n
The AMA procedure seems well-suited to the challenge of monitoring Ivorian patients, as 60% of the local population has a mobile phone. Working with a group of 100 adults and children with lymphoma, AMAFRICA will make it possible to track patients in the active phases of their treatment, and compare treatment adherence and toxicity<\/strong> in regard with patients not receiving phone follow-up during treatment.<\/p>\n*Total dose administered and administration rate.<\/p>\n<\/div>
<\/div><\/div><\/div><\/div><\/div><\/div>KEY FACTS<\/span><\/strong><\/span>
\n_____<\/span><\/p>\nPriority<\/strong><\/span>
\nAccess to quality healthcare<\/span><\/p>\nProgramme<\/strong><\/span>
\nSince December 2015<\/span><\/p>\nType of involvement<\/strong><\/span>
\nDistributor<\/span><\/p>\nActions<\/strong><\/span><\/p>\n\n- Funding for medical examinations (biological and radiological assessments, anatomical-pathological readings),<\/span><\/li>\n
- Equipment funding (anatomical-pathological material, mobiles and communications costs, IT, etc.)<\/span><\/li>\n
- Funding for nurse wages<\/span><\/li>\n
- Funding for physician-clinician missions<\/span><\/li>\n<\/ul>\n<\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div>
<\/span><\/div><\/div>BACKGROUND<\/strong><\/span><\/p>\n<\/div>\n In 2006, at the University Hospital (CHU) of Toulouse, the AMA project was born (Assistance M\u00e9dicale Ambulatoire, or outpatient medical support). Objectives: to assess the effectiveness of telephone follow-up in improving onco-haematology patients\u2019 compliance with dose intensity<\/strong>. Seven years later, the project has show very positive results, with an average dose reduction of 8%, compared to 20% without follow-up \u2013 all due to a simple and inexpensive procedure.<\/p>\n In 2015, Prof. Laurent, encouraged by these achievements, suggested duplicating the study in Ivory Coast, where nearly 20,000 new cancer cases are reported annually, with a 60% treatment refusal and dropout rate, and a 20% survival rate at five years. The project, financed by Fondation Pierre Fabre, took the new name AMAFRICA. A simple, monocentric, randomised study will be conducted in collaboration with the onco-haematology department at the Abidjan University Hospital, headed by Professor Koffi. The central hypothesis is that consistent telephone contact with the patient by a coordinating nurse could reduce the dropout rate (primary objective), but also help identify and prioritise the causes of treatment dropout (secondary objective).<\/p>\n The AMA procedure seems well-suited to the challenge of monitoring Ivorian patients, as 60% of the local population has a mobile phone. Working with a group of 100 adults and children with lymphoma, AMAFRICA will make it possible to track patients in the active phases of their treatment, and compare treatment adherence and toxicity<\/strong> in regard with patients not receiving phone follow-up during treatment.<\/p>\n *Total dose administered and administration rate.<\/p>\n<\/div> KEY FACTS<\/span><\/strong><\/span> Priority<\/strong><\/span> Programme<\/strong><\/span> Type of involvement<\/strong><\/span> Actions<\/strong><\/span><\/p>\n
\n_____<\/span><\/p>\n
\nAccess to quality healthcare<\/span><\/p>\n
\nSince December 2015<\/span><\/p>\n
\nDistributor<\/span><\/p>\n\n
![\"\"](\"https:\/\/www.fondationpierrefabre.org\/wp-content\/uploads\/sites\/2\/2018\/07\/Sans-titre-1-1.png\")
<\/span><\/p>\n